SBI Life Insurance Company Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SBILIFE, BSE:540719 SBI Life Insurance Company Ltd.

SBI Life Insurance Company Ltd.

24 Jan 2021

1819.40

-2.06%

Q3FY21 Result Update - On a gradual recovery mode - Upgrade to 'BUY'

Accumulate: SBI Life Insurance Company...

Recommendation Target

Prabhudas Lilladhar

SBI Life delivered a 7% de-growth in APE on 9MFY21 basis v/s 14% de-growth in H1FY21 on back of 13% NBP YoY. Margins also improved by 50bps to 19.3% from H1 to 9M mainly on higher share of non-PAR especially led by individual protection. Although, in our view, despite mix change & decent volumes margin improvement was slightly slow, offset by faster recovery in ULIPs. Looking from 9MFY21 we increase our estimates with 3% APE growth and margin tailwind from (i) conservative operating assumptions (ii) repricing of certain products especially protection which could see volumepricing impact and (iii) improving growth, helping deliver closer to 20% VNB margins and 19% growth in ROEV for FY21 with tailwinds of same continuing...

SBI Life Insurance Company Ltd. is trading below its 30 day SMA of 1828.3

SBI Life Insurance Company Ltd.

18 Nov 2020

1819.40

-2.06%

Protection trends remain robust; cost leadership continues

Buy: SBI Life Insurance Company...

Target

Motilal Oswal

SBILIFE posted a rebound in business premium with individual APE growing at 14% YoY in Oct'20 after reporting a consecutive decline for the past many months. During 2QFY21, the ULIP business declined 13% YoY but grew 166% QoQ from the troughs seen earlier. Protection growth remains robust both in individual and group segments and is expected it to remain strong. The revival in credit growth, with parent SBIN indicating that the retail disbursement run-rate is now higher than pre-COVID levels, further augurs well for SBILIFE. The company reported an improvement in persistency rate across cohorts, with...

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

SBI Life Insurance Company Ltd.

29 Oct 2020

1819.40

-2.06%

SBI Life Insurance Company

SBI Life Insurance Company...

SMC online

The company has posted 27% growth in net premium collection to Rs 12857.95 crore in Q2FY2021, aided by 28% growth in the renewal business to Rs 7150 crore, while new business premium also jumped 27% to Rs 5940 crore in Q2FY2021. New Business APE eased 4% to Rs 2710 crore in Q2FY2021 from Rs 2810 crore in Q2FY2020. The Value of New Business (VoNB) fell 2% to Rs 510 crore in Q2FY2021, while VoNB margins...

SBI Life Insurance Company Ltd. is trading above its 200 day SMA of 1647.2

SBI Life Insurance Company Ltd.

27 Oct 2020

1819.40

-2.06%

SBI Life Insurance Co. Ltd

Buy: SBI Life Insurance Company...

Target

ICICI Securities Limited

SBI Life Insurance reported a healthy set of numbers led by strong renewal premium and investment income. Higher actuarial liability and elevated claims were offset by steady opex, which led to reasonable PAT growth. Healthy NBP accretion led to elevated commission expenses at | 414 crore, up 1.5% YoY, 83.9% QoQ. Elevated commissions despite higher sourcing via banks (banca + others) were at ~87%. Higher commission expenses were offset by steady opex, leading to overall opex to come in at | 1003 crore vs. | 1014 crore in Q2FY20. Strong premium growth coupled with...

SBI Life Insurance C.. has an average target of 2084.20 from 10 brokers.

SBI Life Insurance Company Ltd.

27 Oct 2020

1819.40

-2.06%

Result Update:SBI Life Insuran

Buy: SBI Life Insurance Company...

Target

Axis Direct

We remain positive on the stock and maintain Buy with a Target Price of Rs 998 (2.8x FY22EV)

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

SBI Life Insurance Company Ltd.

27 Oct 2020

1819.40

-2.06%

Q2FY21 Result Update - Recovery in growth with right business mix - BUY

Buy: SBI Life Insurance Company...

Recommendation Target

Prabhudas Lilladhar

Strong recovery in GWP led by protection & group savings SBI Life delivered 28% YoY growth in GWP mainly from renewal & single premium, while some recovery in regular premiums. This has led to APE recovery with de-growth of -4%/-15% YoY in Q2/H1FY21 vis--vis -32% YoY de-growth in Q1FY21. New business was driven by group savings, protection and recovery in ULIP. This change in business mix kept the margins steady at 18.8% (PLe of 19.6%) as recovery in ULIP offset the protection margin benefit. Improving protection mix and other higher margin products will help...

SBI Life Insurance Company Ltd. is trading above its 200 day SMA of 1647.2

SBI Life Insurance Company Ltd.

27 Oct 2020

1819.40

-2.06%

SBI Life Insura

Buy: SBI Life Insurance Company...

Dolat Capital

SBILIFE reported a 28% YoY increase in GWP to Rs. 130.9bn in Q2FY21 driven by strong renewal premium and single premium, which grew 28% and 71% respectively to Rs 71.5bn and Rs 36.2bn. APE declined 3.5% YoY to Rs. 27.1bn but more than doubled sequentially. The savings APE declined 9.2% to Rs. 23.7bn while the protection APE grew 70% to Rs. 3.4bn. We expect SBILIFE's APE growth to be on par with the industry's. Individual savings APE declined 15% YoY to Rs. 21.1bn and comprise of 78% of the overall mix (Q2FY20: 88% Q1FY21: 75%). Although ULIP APE...

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

SBI Life Insurance Company Ltd.

26 Oct 2020

1819.40

-2.06%

Persistency improves across cohorts; Cost leadership continues

Buy: SBI Life Insurance Company...

Motilal Oswal

Persistency improved across cohorts, with the highest improvement seen in 61st month (by 340bp YoY to 60.9% in 1HFY21), which aided growth in the Renewal business. The company continues to maintain cost leadership, with the total expense ratio declining to 7.7% (~220bp YoY improvement). 2QFY21 shareholders' PAT grew 131% YoY to ~INR3.0b (in-line). Overall, we expect SBILIFE to deliver 17% VNB growth over FY2023E. We further expect VNB margins to improve to ~21% and operating RoEV to...

SBI Life Insurance C.. has an average target of 2084.20 from 10 brokers.

SBI Life Insurance Company Ltd.

26 Oct 2020

1819.40

-2.06%

SBI Life Insura

Buy: SBI Life Insurance Company...

Yes Securities

and revival in the ULIP business. It continues to focus on extracting more from its bancassurance and agency channels. Limited presence on the online platforms, however, is a dampener. The stock trades at FY22E P/EV of 2.1x, which we find...

SBI Life Insurance Company Ltd. is trading below its 30 day SMA of 1828.3

SBI Life Insurance Company Ltd.

06 Aug 2020

1819.40

-2.06%

SBI Life Insurance Company Ltd

Hold: SBI Life Insurance Company...

Recommendation Target

Karvy

Valuation and Outlook: We have valued the stock based on 3.2x forward P/EV and 36.3x forward P/VNB with a premium of 1.02x and has arrived at a price target of Rs. 988 with a potentialupside of 13%. We rate the stock as HOLD'.

Number of FII/FPI investors increased from 897 to 946 in Jun 2025 qtr.

Is SBI Life Insurance Company Ltd. worth buying?

306 Votes:

Buy 75.16%

Sell 14.05%

Hold 10.78%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf